Home
Resources
Publications
The Use of Inositol(s) Isomers in the Management of Polycystic Ovary Syndrome: A Comprehensive Review

The Use of Inositol(s) Isomers in the Management of Polycystic Ovary Syndrome: A Comprehensive Review

Antoaneta Gateva, Vittorio Unfer, Zdravko Kamenov

Gynecol Endocrinol. 2018 Jul;34(7):545-550.

PMID: 29309199

Abstract:

The aim of this review is to present the current data about the role of inositols in the management of polycystic ovary syndrome (PCOS) women and in the prevention and treatment of gestational diabetes mellitus (GDM). We analyzed the available literature with key words PCOS, Myo-inositol, D-chiro-inositol, assisted reproductive technologies and GDM. The most recent literature would suggest that Myo-inositol, D-chiro-inositol and their combination in physiological ratio 40:1 could represent an important therapeutic strategy for the improvement of metabolic, hormonal and reproductive aspects of PCOS. In assisted reproductive technologies, however, myo-inositol and the combined treatment, despite D-chiro-inositol monotherapy, are able to improve clinical outcomes. Myo-inositol monotherapy results more effective in preventing and treating GDM even if a larger cohort of studies is needed to better clarify these results.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP87898-A	Inositol		87-89-8	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: